| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 353 |
| 1 | ACETAMINOPHEN 500MG | 334 |
| 2 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 334 |
| 3 | PAIN RELIEVER | 334 |
| 4 | ESOMEPRAZOLE MAGNESIUM | 333 |
| 5 | ESCITALOPRAM | 308 |
| 6 | VENLAFAXINE HYDROCHLORIDE | 305 |
| 7 | VENLAFAXINE | 301 |
| 8 | ESCITALOPRAM OXALATE | 300 |
| 9 | ESOMEPRAZOLE | 299 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SEROTONIN | 85 | 0.3125 |
| 1 | DENILEUKIN DIFTITOX-CXDL | 1 | 0.1000 |
| 2 | AMLODIPINE AND VALSARTAN | 7 | 0.0355 |
| 3 | ESMOLOL HYDROCHLORIDE IN SODIUM CHLORIDE | 2 | 0.0172 |
| 4 | INSULIN GLARGINE-AGLR | 1 | 0.0130 |
| 5 | TOFACITINIB CITRATE | 166 | 0.0124 |
| 6 | ZOLBETUXIMAB | 12 | 0.0079 |
| 7 | ESMOLOL HYDROCHLORIDE | 2 | 0.0075 |
| 8 | LEMBOREXANT | 21 | 0.0071 |
| 9 | TRAMADOL HYDROCHLORIDE | 252 | 0.0066 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 416 |
| 1 | Proton Pump Inhibitor [EPC] | 388 |
| 2 | Angiotensin 2 Receptor Blocker [EPC] | 345 |
| 3 | Dihydropyridine Calcium Channel Blocker [EPC] | 311 |
| 4 | Calcium Channel Blocker [EPC] | 291 |
| 5 | Corticosteroid [EPC] | 187 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 166 |
| 7 | Kinase Inhibitor [EPC] | 109 |
| 8 | Benzodiazepine [EPC] | 89 |
| 9 | Thalidomide Analog [EPC] | 89 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD25-directed Cytotoxin [EPC] | 1 | 0.1000 |
| 1 | Interleukin-5 Antagonist [EPC] | 11 | 0.0160 |
| 2 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 12 | 0.0079 |
| 3 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 13 | 0.0057 |
| 4 | Adrenal Steroid Synthesis Inhibitor [EPC] | 5 | 0.0050 |
| 5 | Endoglycosidase [EPC] | 8 | 0.0043 |
| 6 | Plasma Kallikrein Inhibitor [EPC] | 8 | 0.0033 |
| 7 | CD38-directed Cytolytic Antibody [EPC] | 18 | 0.0031 |
| 8 | Neonatal Fc Receptor Blocker [EPC] | 11 | 0.0025 |
| 9 | CD19-directed Chimeric Antigen Receptor [EPC] | 23 | 0.0023 |